Advertisement

Picture Kentro Design Is Key to Your Success Berlin 650x100px
Document › Details

CRISPR Therapeutics AG. (2/21/23). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results". Zug & Boston, MA.

Organisations Organisation CRISPR Therapeutics AG (Nasdaq: CRSP)
  Group CRISPR Therapeutics (Group)
  Organisation 2 Vertex Pharmaceuticals Inc. (Nasdaq: VRTX)
  Group Vertex Pharmaceuticals (Group)
Products Product exagamglogene autotemcel (exa-cel) (formerly CTX001)
  Product 2 CTX130 allogeneic CAR T-cell therapy
Persons Person Harding, Alex (CRISPR Therapeutics 202301– Head BusDev before Remix Theraepeutics + Atlas Venture)
  Person 2 Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO)
     


   
Record changed: 2024-01-20

Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for CRISPR Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top